Atomera (ATOM) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Announced a strategic partnership and joint marketing agreement with a major capital equipment provider to accelerate MST adoption and boost license revenues, particularly in gate-all-around and advanced memory applications.
Expanded customer engagements, including STMicro, RF-SOI, and memory providers, with over 21 customers and 26 active engagements, covering more than half of the world's top semiconductor makers.
Achieved a milestone with the world's first MST-enabled GaN devices in partnership with Sandia National Labs, with promising early electrical results and ongoing testing.
Focused on licensing MST technology for transistor enhancement in the $550–$600 billion semiconductor market, with a business model centered on licensing and royalties.
Actively recruiting to support increased customer activity and transition to high-volume production.
Financial highlights
Q1 2025 revenue was $4,000, down from $18,000 in Q1 2024, reflecting limited commercial activity.
Q1 2025 GAAP net loss was $5.2 million ($0.17/share), compared to $4.8 million ($0.19/share) in Q1 2024; adjusted EBITDA loss was $4.4 million.
Q1 2025 GAAP operating expenses were $5.5 million, up from $5.0 million year-over-year, mainly due to higher R&D and legal expenses.
Cash, cash equivalents, and short-term investments totaled $24.1 million as of March 31, 2025, down from $26.8 million at year-end.
Raised $2.4 million via ATM facility in Q1, selling 163,000 shares at an average price of $15.19; ATM program expired March 18, 2025.
Outlook and guidance
Q2 2025 revenue expected in the range of $0–$50,000, dependent on wafer shipments to a fabless licensee.
Full-year 2025 non-GAAP operating expense projected at $17.25–$17.75 million, reflecting increased R&D and planned headcount additions.
Management expects available working capital to fund operations for at least the next 12 months; future capital needs depend on commercialization success.
Continued focus on expanding MST adoption across power, RF-SOI, advanced nodes, DRAM, and GaN/Si applications, with ongoing electrical characterization of MST-enabled GaN devices.
Next major revenue milestone with STMicro anticipated upon formal process qualification.
Latest events from Atomera
- Q1 2026 net loss widened to $6.1M, offset by $25M equity raise and MST technology advances.ATOM
Q1 20265 May 2026 - Key votes include director elections, auditor ratification, and a stock authorization increase.ATOM
Proxy filing27 Mar 2026 - Shareholders will vote on director elections, auditor ratification, share increase, and executive pay.ATOM
Proxy filing27 Mar 2026 - Virtual meeting to vote on directors, auditor, share increase, and executive pay; strong governance focus.ATOM
Proxy Filing17 Mar 2026 - Technical advances and new customer traction amid losses and strong industry demand.ATOM
Q4 202513 Feb 2026 - Q2 2024 net loss narrowed, revenue rose, and MST technology advances amid ongoing risks.ATOM
Q2 20242 Feb 2026 - Q3 2024 net loss narrowed to $4.6M, revenue stayed low, and cash reserves remain solid.ATOM
Q3 202418 Jan 2026 - MST drives performance gains for semiconductors, targeting growth through licensing and industry alliances.ATOM
27th Annual Needham Growth Conference10 Jan 2026 - At-the-market offering of up to $50M in stock to fund growth, with significant dilution risk.ATOM
Registration Filing16 Dec 2025